日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Application given for gene therapy trials to treat blood disease

By Liu Zhihua | chinadaily.com.cn | Updated: 2021-01-19 14:44
Share
Share - WeChat
A screenshot from EdiGene's official website. [Photo/edigene.com]

Chinese biotech company EdiGene Inc announced on Monday the Center for Drug Evaluation of the China National Medical Products Administration has approved the company's Investigational New Drug application for ET-01, a CRISPR/Cas 9 gene-editing therapy for patients with transfusion dependent β-thalassemia, a blood disease characterized by severe anemia and a lifelong dependence on red blood cell transfusions that can lead to iron overload.

That marks the first gene-editing therapy and the first hematopoietic stem cell therapy IND application approval in China.

The Beijing-based company develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases. Previously, the company announced the acceptance of the IND by CDE on Oct 27, 2020.

Wei Dong, CEO of EdiGene, said the company will roll out phase I clinical trials soon.

"We are embarking on a new journey as a clinical-stage company. We will continue to translate cutting-edge gene-editing technology and advance our pipeline, with a goal of providing better choices for patients in China and around the world," he said.

ET-01 is an investigational, autologous, ex vivo gene-editing therapy. The approved trial of ET-01 is a multicenter, open-label, single arm study designed to assess safety and efficacy in transfusion dependent β-thalassemia patients.

In China, it is estimated there are over 300,000 patients with thalassemia major or thalassemia intermediate. Serious unmet medical needs remain for transfusion dependent β-thalassemia patients today.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 久久99精品久久久久久噜噜 | 成人高清 | 久久久久亚洲精品 | 男女全黄做爰视频免费看 | 超级碰在线视频 | 亚洲涩涩 | 欧美国产精品一区二区免费 | 美女扣下面流白浆丝袜 | 五月婷婷激情六月 | 国产色情A片国语露对白 | 日韩欧美一区二区三区免费观看 | 国产精品人妻一区夜夜爱 | 亚洲精品国产电影 | 国产色婷婷视频在线观看 | 免费一级做a爰片性视频 | www.99精品视频在线播放 | 天天干天天干 | 欧美成人激情在线 | 日本黄色激情视频 | 国产婷婷精品av在线 | 久久久久久全国免费观看 | 狠狠综合久久久久综 | 色噜噜狠狠狠狠色综合久不 | 国产精品久久久久久久一区探花 | 四虎网址| 免费观看国产大片资源视频 | 亚洲欧洲日韩国产aa色大片 | 欧美a视频在线观看 | 欧美精品激情 | 中文字幕 在线观看 | 日本亚洲精品色婷婷在线影院 | 天天色色色 | 欧美一区二区三区四区不卡 | 日韩精品一级毛片 | 无码AV免费一区二区三区A片 | av网站免费看 | 成人在线精品视频 | 免费在线小视频 | 免费高清成人啪啪网站 | 色婷婷一区二区三区四区 | 成人黄色免费观看 |